Sinopsys has developed a medical device, which is indicated to maintain an opening to the ethmoid sinus for administration of saline irrigation and potentially ophthalmic drugs directly into the ethmoid sinuses.
Location: United States, Colorado, Boulder
Investors 2
| Date | Name | Website |
| - | Mercury Fu... | mercuryfun... |
| - | Creathor V... | creathor.c... |
Mentions in press and media 4
| Date | Title | Description |
| 24.10.2014 | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | $4.1 million in equity raised of a proposed $10 million According to Phase IIa trials, its drug – levetiracetam – is showing promise in treating the mild cognitive decline that often results in Alzheimer’s. The drug’s usually used to treat ... |
| 24.10.2014 | Sinopsys Surgical gains $8.3M funding round for sinusitis device | Medtech funding for the week of October 20, 2014 | Sinopsys Surgical sniffs up $8.3m for sinusitis device October 17, 2014 by Alexander Soule Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it’s developing to repurpose the tear... |
| 17.10.2014 | Sinopsys Surgical sniffs up $8.3m for sinusitis device | Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it’s developing to repurpose the tear duct to drain into the sinuses as a way to relieve chronic sinusitis. CEO Dr. Harry Ross w... |
| - | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC. Here are the new funding notices fro... |